We have been able to reverse the scar tissue in the liver and there is no drug on the market that does this today.
(PRWEB) August 29, 2013
At the recent FSXinterlinked Investment Conference, held at the Ritz Carlton in Fort Lauderdale, Florida, Galectin Therapeutics' Executive Chairman, Jim Czirr, granted an exclusive interview for the FSXinterlinked channel on InterlinkedTV.
Galectin Therapeutics is a development-stage company, engaged in the discovery and development of therapeutics for the treatment of cancer, liver, microbial, and inflammatory diseases. Galectin Therapeutics is applying its leadership in galectin science and drug development to create new therapies for fibrotic disease and cancer. The company’s drug candidates are based on unique carbohydrate technology to target galectin proteins, which are key mediators of biologic and pathologic function. Galectin Therapeutics leverages extensive scientific and development expertise as well as established relationships with outside sources to achieve cost effective and efficient development. The company is pursuing a clear development pathway to clinical enhancement and commercialization for lead compounds in liver fibrosis and cancer immunotherapy.
During the interview, Mr. Czirr stated that "In our pre-clinical studies, we have already treated mice, rats and monkeys, and we have been able to reverse the scar tissue in the liver; there is no drug on the market that does this today." He added "So the millions of people that have fatty liver disease with cirrhosis, which by the way number more than people who have cancer, so this is a silent epidemic of people who have great need for this drug, we represent their best hope right now. We are very excited about the opportunity to affect so many people's lives positively."
About FSXinterlinked Investment Conference
FSXinterlinked is the premier investment conference organization in the United States. Founded as Financial Services Exchange (FSX) in 1983, it is a national organization comprised of independent FINRA broker/dealer firms and private equity fund managers. With quarterly investment conferences hosted throughout the U.S., FSXinterlinked creates a forum for emerging growth companies seeking capital to present to a nationwide network of financial investment professionals.
The FSXinterlinked network of independent broker/dealers has a combined sales force of thousands of accredited investors looking to invest in companies of all sizes and industries. To date, more than $3 billion has been raised for presenting companies through the FSXinterlinked network. FSXinterlinked’s exclusive network of FINRA firms makes the investment conferences the ideal setting for private and public companies seeking mezzanine financing, funding for private placements, IPOs, secondary financing and pipes, exposure, and more. For more information, visit http://www.fsxinterlinked.com/.
Interlinked is a global investment community of accredited investors, emerging growth companies, and resource partners. Interlinked offers an efficient way for companies to maximize exposure and access a private network of funding sources and verified service providers. For investors, Interlinked provides a secure environment to find, vet and engage companies, and communicate with members. Interlinked gives members exclusive access to a proprietary investment platform, which integrates virtual data rooms, video news, a service provider marketplace, an event directory, and customized marketing services, including email marketing, video production, public relations and more. For more information, visit: http://www.interlinked.com/.
Safe Harbor Statement
This press release may contain information that constitutes forward-looking statements made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. All statements, trends, analysis, and other information contained in this press release, including words such as “anticipate,” “believe,” “plan,” “estimate,” “expect,” “intend,” and other similar expressions of opinion, constitute forward-looking statements. Any such forward-looking statements involve risks and uncertainties that could cause actual results to differ materially from any future results described within the forward-looking statements. Risk factors that could contribute to such differences include those matters more fully disclosed in the Company’s reports filed with the Securities and Exchange Commission. The forward-looking information provided herein represents the Company’s estimates as of the date of the press release, and subsequent events and developments may cause the Company’s estimates to change. The Company specifically disclaims any obligation to update the forward-looking information in the future. Therefore, this forward-looking information should not be relied upon as representing the Company’s estimates of its future financial performance as of any date subsequent to the date of this press release.